期刊文献+

内科住院患者静脉血栓栓塞症的预防 被引量:7

Prevention of venous thromboembolism in hospitalized medical patients
原文传递
导出
摘要 现已明确,对有静脉血栓栓塞症(VTE)高危风险的内科住院患者给予血栓预防措施可明确降低VTE的发病率和病死率。2009年我国颁布了"内科住院患者静脉血栓栓塞症预防的中国专家建议"〔1〕。2012年美国胸科医师学会颁布了血栓形成抗栓治疗和预防第9版指南〔2〕,此文对该指南中有关内科住院患者VTE预防的建议进行解读。 Venous thromboembolism (VTE) ,which encompasses deep vein thrombosis (DVT) and pulmona- ry embolism (PE) ,is a leading cause of mortality following hospitalization. 70% to 80% of inpatient deaths due to pulmonary embolism ocurr in medical patients. Identifying medical patients at risk for VTE and providing effective prophylaxis is now an important health care priority to reduce the burden of this morbid and sometimes fatal dis- ease. Pharmacologic prophylaxis is the mainstay of VTE prevention. Multiple scientific guidelines support VTE prophylaxis in medical patients.
出处 《临床急诊杂志》 CAS 2013年第2期93-96,共4页 Journal of Clinical Emergency
关键词 静脉血栓栓塞症 深静脉血栓形成 肺栓塞 预防 venous thromboembolism deep vein thrombosis pulmonary embolism prevention
  • 相关文献

参考文献20

  • 1李小鹰,王辰.内科住院患者静脉血栓栓塞症预防的中国专家建议[J].中华结核和呼吸杂志,2009,32(1):3-8. 被引量:32
  • 2KAHN S, LIM W, DUNN A S, et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed.. american college of chest physicians evidence-based clinical practice guidelines[J].Chest, 2012,141: e195S- e226S.
  • 3STEVENS S M,DOUKETIS J D. Deep vein thrombo- sis prophylaxis in hospitalized medical patients: cur- rent recommendations, general rates of implementa- tion, and initiatives for improvement[J]. Chin Chest Med, 2010,31 : 675- 689.
  • 4SPENCER F A, LESSARD D, EMERY C, et al. Ve- nous thromboembolism in the outpatient setting[J]. Arch Intern Med, 2007,167 : 1471- 1475.
  • 5LLOYD N S,DOUKETIS J D, MOINUDDIN I, et al. Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis[J]. J Thromb Haemost, 2008,6 : 405- 414.
  • 6PIAZZA G,FANIKOS J ,ZAYARUZNY M,et al. Ve- nous thromboembolic events in hospitalised medical patients[J]. Thromb Haemost, 2009,102 : 505- 510.
  • 7CAPRINI J A, ARCELUS J,SEHGAL L R, et al. The use of low molecular weight heparins for the preven- tion of postoperative venous thromboembolism in gen- eral surgery. A survey of practice in the United States [J]. Int Angiol, 2002,21 : 78- 85.
  • 8BARBAR S, NOVENTA F, ROSSETTO V, et al. A risk assessment model for the identification of hospi- talized medical patients at risk for venous thromboem-bolism: the Padua Prediction Score[J].J Thromb Hae- most,2010,8:2450-2457.
  • 9DECOUSUS H, TAPSON V F, BERGMANN J F, e* al. IMPROVE Investigators. Factors at admission as sociated with bleeding risk in medical patients: find- ings from the IMPROVE investigators [J]. Chest, 2011,139:69-79.
  • 10I KIERKEGAARD A, NORGREN L. Graduated com- pression stockings in the prevention of deep vein thrombosis in patients with acute myocardial infarc- tion[J]. Eur Heart J,1993,14:1365-1368.

二级参考文献64

  • 1Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med, 1989, 82: 203-205.
  • 2Cardiovascular Disease Educational and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust, European Venous Forum, et al. Prevention and treatment of venous thromboembolism. International Consensus statement (guidelines according to scientific evidence). Int Angiol, 2006, 25 : 101- 161.
  • 3Samama MM, Cohen AT, Darmon JY, et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med, 1999, 341 : 793-800.
  • 4Leizorovicz A, Mismetti P. Preventing venous thromboembolism in medical patients. Circulation, 2004, 110 Suppl 1: IV13-IV19.
  • 5Cohen AT, Davidson BL, Gallus AS, et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomized placebo controlled trial. BMJ, 2006, 332: 325-329.
  • 6Fraisse F, Holzapfel L, Couland JM, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med, 2000, 161: 1109-1114.
  • 7Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA, 1995, 274: 335-337.
  • 8Spyropoulos AC. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. Chest, 2005, 128 : 958-969.
  • 9Cohen AT, Alikhan R, Arcelus JI, et al. Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost, 2005, 94: 750-759.
  • 10Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ, 1991, 302 : 709-711.

共引文献35

同被引文献79

  • 1张帅,陈娟红,富燕萍,姚惠萍.应用集束化措施降低主动脉夹层患者术后谵妄的护理实践[J].中华急危重症护理杂志,2020,1(4):328-331. 被引量:8
  • 2张金辉,郭修海,金辉.特发性静脉血栓栓塞与血栓形成倾向研究进展[J].中国血管外科杂志(电子版),2012,4(1):53-56. 被引量:2
  • 3李桂源主编.病理生理学[M].2版.北京:人民卫生出版社,2010:34-38.
  • 4DOUKETIS J D,SPYROPOULOS A C,SPENCER FA, et al. Perioperative management of antithrombotictherapy: Antithrombotic therapy and prevention ofthrombosis,9th ed: American College of Che'st Physi-ciarivS evidence-based clinical practice guidelines [J].CHEST,2012,141(2 Suppl 1) :e326S-e350S.
  • 5DOUKETIS J D. Perioperative management of pa-tients who are receiving warfarin therapy: an evi-dence-based and practical approach [J Blood, 2011,117:5044-5049.
  • 6SPYROPOULOS A C. Bridging therapy and oral anti-coagulation: current and future prospects [J]. CurrOpin Hematol, 2010,17 : 444 —449.
  • 7THACHIL J’GATT A,MARTLEW V. Managementof surgical patients receiving anticoagulation and anti-platelet agents[J]. Br J Surg,2008,95 : 1437 — 1448.
  • 8JAFFER A K. Perioperative management of warfarinand antiplatelet therapy[J]. Cleve Clin J Med, 2009 ,76-S37-S44.
  • 9SPYROPOULOS A C, DOUKETIS J D. Guidelinesfor antithrombotic therapy: periprocedural manage-ment of antithrombotic therapy and use of bridginganticoagulation[J]. Int Angiol,2008,27:333 —343.
  • 10JAFF M R. Chronically anticoagulated* patients whoneed surgery : can lowmolecular-weight heparins reallybe used to -bridge*- patients instead of intravenous un-fractionated heparin[J]. Catheter Cardiovasc Interv,2009,74:S17-S21.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部